RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist
Article in Frontiers in Oncology (May 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (May 2023)
Article in Drugs (March 2023)
Article in International Medical Case Reports Journal (December 2022)